Novavax, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
61.50
|
|
Average Rating
|
3.83
|
|
# Strong Buys
|
3
|
|
# Buys
|
1
|
|
# Holds
|
0
|
|
# Sells
|
2
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
1.57
|
-2.15
|
-3.72
|
-236.94%
|
|
2022-06-30
|
5.50
|
-6.53
|
-12.03
|
-218.73%
|
|
2022-03-31
|
2.69
|
2.56
|
-0.13
|
-4.83%
|
|
2021-12-31
|
-1.80
|
-11.18
|
-9.38
|
-521.11%
|
|
2021-09-30
|
-3.91
|
-4.31
|
-0.40
|
-10.23%
|
|
2021-06-30
|
-3.63
|
-4.75
|
-1.12
|
-30.85%
|
|
2021-03-31
|
-3.60
|
-3.05
|
0.55
|
15.28%
|
|
2020-12-31
|
-1.49
|
-2.70
|
-1.21
|
-81.21%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-6.12
|
|
2021-12-31
|
-23.29
|
|
2020-12-31
|
-6.79
|
|
2019-12-31
|
-5.76
|
|
2018-12-31
|
-10.20
|
|
2017-12-31
|
-9.56
|
|
2016-12-31
|
-1.03
|
|
2015-12-31
|
-0.59
|
|
2014-12-31
|
-3.21
|
|
2013-12-31
|
-6.20
|
|
2012-12-31
|
-4.60
|
|
2011-12-31
|
-3.20
|
|
2010-12-31
|
-7.20
|
|
2009-12-31
|
-9.00
|
|
2008-12-31
|
-10.60
|
|
2007-12-31
|
-11.40
|
|
2006-12-31
|
-7.80
|
|
2005-12-31
|
-5.80
|
|
2004-12-31
|
-14.03
|
|
2003-12-31
|
-12.00
|
|
2002-12-31
|
-17.80
|
|
2001-12-31
|
-8.60
|
|
2000-12-31
|
-17.57
|
|
1998-12-31
|
-15.33
|